SGLT2i in CKD: How to overcome clinical inertia?
Meeting report with videos, slides and e-learning of a PACE-CME symposium during virtual ERA-EDTA 2021 on the evolving role of SGLT2i in cardiovascular and kidney protection.
Episodes 1-3 of 3
Prof. Peter Rossing, MD
- SGLT2i in CKD: How to overcome clinical inertia?Practical challenges with SGLT2i therapy in patients with T2DM and CKD
Alice Cheng, MD
- SGLT2i in CKD: How to overcome clinical inertia?Clinical inertia in CKD - What is the rationale for SGLT2i?
Janaka Karalliedde, MD, PhD
